-
1
-
-
0031784963
-
Botulinum toxin type A for facial rejuvenation. United States and United Kingdom perspectives
-
Lowe NJ. Botulinum toxin type A for facial rejuvenation. United States and United Kingdom perspectives. Dermatol Surg 1998;24(11):1216-8.
-
(1998)
Dermatol. Surg.
, vol.24
, Issue.11
, pp. 1216-1218
-
-
Lowe, N.J.1
-
3
-
-
0348179211
-
Cervical dystonia: Treatment with botulimun toxin serotype A as Botox or Dysport
-
Brin MF, Jankovic J, Hallett M, editors. Philadelphia: Lippincott Williams & Williams
-
Comella CL. Cervical dystonia: treatment with botulimun toxin serotype A as Botox or Dysport. In: Brin MF, Jankovic J, Hallett M, editors. Scientific and therapeutic aspects of botulinum toxin. Philadelphia: Lippincott Williams & Williams; 2002. p. 359-64.
-
(2002)
Scientific and Therapeutic Aspects of Botulinum Toxin
, pp. 359-364
-
-
Comella, C.L.1
-
4
-
-
0033876785
-
Botulinum toxin in the treatment of tics
-
Kwak CH, Hanna PA, Jankovic J. Botulinum toxin in the treatment of tics. Arch Neurol 2000;57(8):1190-3.
-
(2000)
Arch. Neurol.
, vol.57
, Issue.8
, pp. 1190-1193
-
-
Kwak, C.H.1
Hanna, P.A.2
Jankovic, J.3
-
5
-
-
0035076007
-
Pharmacology and immunology of botulinum toxin serotypes
-
Aoki KR. Pharmacology and immunology of botulinum toxin serotypes. J Neurol 2001;248(Suppl 1):3-10.
-
(2001)
J. Neurol.
, vol.248
, Issue.SUPPL. 1
, pp. 3-10
-
-
Aoki, K.R.1
-
6
-
-
85030915836
-
-
Product Information Package Insert. (71390US12J). Irvine, California: Allergan Inc
-
Product Information Package Insert. (71390US12J). Irvine, California: Allergan Inc.; 2002.
-
(2002)
-
-
-
8
-
-
0031782357
-
Complications of botulinum A exotoxin for hyperfunctional lines
-
Matarasso SL. Complications of botulinum A exotoxin for hyperfunctional lines. Dermatol Surg 1998;24(11): 1249-54.
-
(1998)
Dermatol. Surg.
, vol.24
, Issue.11
, pp. 1249-1254
-
-
Matarasso, S.L.1
-
9
-
-
0036621625
-
A multi-center, double-blind, randomized, placebo-controlled study of the efficacy and safety of botulinum toxin type A in the treatment of glabellar lines
-
Carruthers JA, Lowe NJ, Menter MA, et al. A multi-center, double-blind, randomized, placebo-controlled study of the efficacy and safety of botulinum toxin type A in the treatment of glabellar lines. J Am Acad Dermatol 2002;46(6):840-9.
-
(2002)
J. Am. Acad. Dermatol.
, vol.46
, Issue.6
, pp. 840-849
-
-
Carruthers, J.A.1
Lowe, N.J.2
Menter, M.A.3
-
10
-
-
0035168738
-
Current practices in the use of botulinum toxin A in the management of facial lines and wrinkles
-
Blitzer A, Binder WJ, Aviv JE. Current practices in the use of botulinum toxin A in the management of facial lines and wrinkles. Facial Plast Surg Clin N Am 2001; 9(3):395-404.
-
(2001)
Facial Plast. Surg. Clin. N. Am.
, vol.9
, Issue.3
, pp. 395-404
-
-
Blitzer, A.1
Binder, W.J.2
Aviv, J.E.3
-
11
-
-
0003984768
-
-
56th edition. Montvale (NJ): Thompson Medical Economics
-
Physicians Desk Reference. 56th edition. Montvale (NJ): Thompson Medical Economics; 2002.
-
(2002)
Physicians Desk Reference
-
-
-
12
-
-
0004122190
-
-
13th edition. St. Louis (MO): Mosby
-
Mosby's Drug Consult. 13th edition. St. Louis (MO): Mosby; 2003.
-
(2003)
Mosby's Drug Consult
-
-
-
14
-
-
0348179306
-
Clinical botulism
-
Brin MF, Jankovic J, Hallett M, editors. Philadelphia: Lippincott Williams & Williams
-
Arnon SS. Clinical botulism. In: Brin MF, Jankovic J, Hallett M, editors. Scientific and therapeutic aspects of botulinum toxin. Philadelphia: Lippincott Williams & Williams; 2002. p. 145-50.
-
(2002)
Scientific and Therapeutic Aspects of Botulinum Toxin
, pp. 145-150
-
-
Arnon, S.S.1
-
15
-
-
0000270992
-
Botulinum toxin: Chemistry, pharmacology, toxicity, and immunology
-
Brin MF. Botulinum toxin: chemistry, pharmacology, toxicity, and immunology. Muscle Nerve Suppl 1997; 6:S208-20.
-
(1997)
Muscle Nerve Suppl.
, vol.6
-
-
Brin, M.F.1
-
17
-
-
0021705715
-
Acute toxicity of aminoglycosides antibiotics as an aid to detecting botulism
-
Wang YC, Burr DH, Korthals GJ, et al. Acute toxicity of aminoglycosides antibiotics as an aid to detecting botulism. Appl Environ Microbiol 1984;48:951-5.
-
(1984)
Appl. Environ. Microbiol.
, vol.48
, pp. 951-955
-
-
Wang, Y.C.1
Burr, D.H.2
Korthals, G.J.3
-
18
-
-
0026610788
-
Neuromuscular blockade and ventilatory failure after cyclosporine
-
Kadieva VS, Friedman L, Margolius LP, et al. Neuromuscular blockade and ventilatory failure after cyclosporine. Can J Anesth 1992;39:402-3.
-
(1992)
Can. J. Anesth.
, vol.39
, pp. 402-403
-
-
Kadieva, V.S.1
Friedman, L.2
Margolius, L.P.3
-
19
-
-
0017560491
-
Myasthenia associated with D-penicillamine therapy in rheumatoid arthritis
-
Bucknall RC. Myasthenia associated with D-penicillamine therapy in rheumatoid arthritis. Proc R Soc Med 1977;70(Suppl 3):114-7.
-
(1977)
Proc. R. Soc. Med.
, vol.70
, Issue.SUPPL. 3
, pp. 114-117
-
-
Bucknall, R.C.1
-
20
-
-
0019209045
-
Penicillamine-associated myasthenia gravis
-
Albers JW, Hodach RJ, Kimmel DW, et al. Penicillamine-associated myasthenia gravis. Neurology 1980; 30:1246-9.
-
(1980)
Neurology
, vol.30
, pp. 1246-1249
-
-
Albers, J.W.1
Hodach, R.J.2
Kimmel, D.W.3
-
21
-
-
0019956937
-
The interaction between aminoquinolones and presynaptically acting neurotoxins
-
Simpson LL. The interaction between aminoquinolones and presynaptically acting neurotoxins. J Phamacol Exp Ther 1982;222:43-8.
-
(1982)
J. Phamacol. Exp. Ther.
, vol.222
, pp. 43-48
-
-
Simpson, L.L.1
-
22
-
-
0025863552
-
Distant effects of locally injected botulinum toxin: A double-blind study of single fiber EMG changes
-
Lange DJ, Rubin M, Greene PE, et al. Distant effects of locally injected botulinum toxin: a double-blind study of single fiber EMG changes. Muscle Nerve 1991;14: 672-5.
-
(1991)
Muscle Nerve
, vol.14
, pp. 672-675
-
-
Lange, D.J.1
Rubin, M.2
Greene, P.E.3
-
23
-
-
0033023671
-
Strucutre, activity, and immune (T and B cell) recognition of botulinum neurotoxins
-
Atassi MZ, Oshima M. Strucutre, activity, and immune (T and B cell) recognition of botulinum neurotoxins. Crit Rev Immunol 1999;19:219-60.
-
(1999)
Crit. Rev. Immunol.
, vol.19
, pp. 219-260
-
-
Atassi, M.Z.1
Oshima, M.2
-
24
-
-
0035009662
-
Botulinum toxin aniotbody testing: Comparisson between an immunoprecipitation assay and the mouse diaphragm assay
-
Dressler D, Dirnberger G, Bhatia L, et al. Botulinum toxin aniotbody testing: comparisson between an immunoprecipitation assay and the mouse diaphragm assay. Eur Neurol 2001;45:257-60.
-
(2001)
Eur. Neurol.
, vol.45
, pp. 257-260
-
-
Dressler, D.1
Dirnberger, G.2
Bhatia, L.3
-
25
-
-
0028059275
-
Botalinum toxin in movement disorders
-
Jankovic J. Botalinum toxin in movement disorders. Curr Opin Neurol 1994;7:358-66.
-
(1994)
Curr. Opin. Neurol.
, vol.7
, pp. 358-366
-
-
Jankovic, J.1
-
26
-
-
0032239987
-
Depletion of neutralizing antibodies resensitises non-responder to botulinum A neurotoxin
-
Naumann M, Toyka KV, Mansour TB, et al. Depletion of neutralizing antibodies resensitises non-responder to botulinum A neurotoxin. J Neurol Neurosurg Psychiatry 1998;65:924-7.
-
(1998)
J. Neurol. Neurosurg. Psychiatry
, vol.65
, pp. 924-927
-
-
Naumann, M.1
Toyka, K.V.2
Mansour, T.B.3
-
27
-
-
0028345811
-
Development of resistance to botulinum toxin A in patients with torticollis
-
Greene P, Fahn S, Diamond B. Development of resistance to botulinum toxin A in patients with torticollis. Movement Disorder 1994;9:213-7.
-
(1994)
Movement Disorder
, vol.9
, pp. 213-217
-
-
Greene, P.1
Fahn, S.2
Diamond, B.3
-
28
-
-
0002267607
-
Immunogenecity of the neurotoxins of Clostriduim botulinum
-
Jankovic J, Hallett M, editors. New York: Dekker
-
Hatheway CL, Dang C. Immunogenecity of the neurotoxins of Clostriduim botulinum. In: Jankovic J, Hallett M, editors. Therapy with Botulinum toxin. New York: Dekker; 1994. p. 93-107.
-
(1994)
Therapy With Botulinum Toxin
, pp. 93-107
-
-
Hatheway, C.L.1
Dang, C.2
-
29
-
-
0031239673
-
Botulinum toxin therapy, Neutralizing and non-neutralizing antibodies
-
Goschel H, Wohlfarth K, Frevert J, et al. Botulinum toxin therapy, Neutralizing and non-neutralizing antibodies. Exp Neurol 1997;147(1):96-102.
-
(1997)
Exp. Neurol.
, vol.147
, Issue.1
, pp. 96-102
-
-
Goschel, H.1
Wohlfarth, K.2
Frevert, J.3
-
30
-
-
0036198554
-
Botulinum yoxin
-
American Society of Plastic Surgeons DATA Committee
-
Matarasso A, Deva K, et al, American Society of Plastic Surgeons DATA Committee. Botulinum yoxin. Plast Reconstr Surg 2002;109(3):1191-7.
-
(2002)
Plast. Reconstr. Surg.
, vol.109
, Issue.3
, pp. 1191-1197
-
-
Matarasso, A.1
Deva, K.2
-
31
-
-
0002988277
-
Botulinum toxin: Clinical implications of antigeniticity and immunoresistance
-
Brin MF, Jankovic J, Hallet M, editors. Philadelphia: Lippincott Williams & Williams
-
Jankovic J. Botulinum toxin: clinical implications of antigeniticity and immunoresistance. In: Brin MF, Jankovic J, Hallet M, editors. Scientific and therapeutic aspects of botulinum toxin. Philadelphia: Lippincott Williams & Williams; 2002. p. 409-15.
-
(2002)
Scientific and Therapeutic Aspects of Botulinum Toxin
, pp. 409-415
-
-
Jankovic, J.1
-
32
-
-
0036560715
-
Botulinum toxin type B (Myobloc) in the management of hyperkinetic facial lines
-
Ramirez AL, Reeck J, Maas CS. Botulinum toxin type B (Myobloc) in the management of hyperkinetic facial lines. Otolaryngol Head Neck Surg 2002;126:459-67.
-
(2002)
Otolaryngol. Head Neck Surg.
, vol.126
, pp. 459-467
-
-
Ramirez, A.L.1
Reeck, J.2
Maas, C.S.3
-
33
-
-
0036713969
-
Botulinum toxin type B (myoblock) for glabellar wrinkles: A prospective open-label response study
-
Sadick NS. Botulinum toxin type B (myoblock) for glabellar wrinkles: a prospective open-label response study. Dermatol Surg 2002;29:817-21.
-
(2002)
Dermatol. Surg.
, vol.29
, pp. 817-821
-
-
Sadick, N.S.1
-
35
-
-
0001339033
-
Clostridial toxins as therapeutic agents
-
Simpson L, editor. New York: Academic Press
-
Scott AB. Clostridial toxins as therapeutic agents. In: Simpson L, editor. Botulinum neurotoxin and tentanus toxin. New York: Academic Press; 1989. p. 399-406.
-
(1989)
Botulinum Neurotoxin and Tentanus Toxin
, pp. 399-406
-
-
Scott, A.B.1
-
36
-
-
0025857556
-
Therapeutic uses of botulinum toxin
-
Jankovic N, Brin MF. Therapeutic uses of botulinum. toxin. N Engl J Med 1991;324(17):1186-93.
-
(1991)
N. Engl. J. Med.
, vol.324
, Issue.17
, pp. 1186-1193
-
-
Jankovic, N.1
Brin, M.F.2
-
37
-
-
0032951652
-
Long-term treatment of cervical dystonia with BTX-A: Efficacy, safety, and antibody frequency
-
German Dystonia Study Group
-
Kessler KR, Skutta M, Benecke R. Long-term treatment of cervical dystonia with BTX-A: efficacy, safety, and antibody frequency. German Dystonia Study Group. J Neurol 1999;246:265-74.
-
(1999)
J. Neurol.
, vol.246
, pp. 265-274
-
-
Kessler, K.R.1
Skutta, M.2
Benecke, R.3
-
38
-
-
0036893981
-
Bilateral, double-blind, randomized comparison of 3 doses of botulinum toxin type A and placebo in patient with crow's feet
-
Lowe NJ, Lask G, Yamauchi P, et al. Bilateral, double-blind, randomized comparison of 3 doses of botulinum toxin type A and placebo in patient with crow's feet. J Am Acad Dermatol 2002;47(6):834-40.
-
(2002)
J. Am. Acad. Dermatol.
, vol.47
, Issue.6
, pp. 834-840
-
-
Lowe, N.J.1
Lask, G.2
Yamauchi, P.3
-
40
-
-
0031751613
-
Clinical indications and injection technique for the cosmetic use of botulinum A exotoxin
-
Carruthers A, Carruthers J. Clinical indications and injection technique for the cosmetic use of botulinum. A exotoxin. Dermatol Surg 1998;24(11):1189-94.
-
(1998)
Dermatol. Surg.
, vol.24
, Issue.11
, pp. 1189-1194
-
-
Carruthers, A.1
Carruthers, J.2
-
41
-
-
0036219395
-
Pain associated with injection of botulinumn toxin A exotoxin reconstituted using isotonic sodium chloride with and without preservative
-
Alam M, Dover JS, Arndt KA. Pain associated with injection of botulinumn toxin A exotoxin reconstituted using isotonic sodium chloride with and without preservative. Arch Deramtol 2002;138:510-4.
-
(2002)
Arch. Deramtol.
, vol.138
, pp. 510-514
-
-
Alam, M.1
Dover, J.S.2
Arndt, K.A.3
-
42
-
-
0035076007
-
Pharmacology and immunology of botulinum toxin serotypes
-
Aoki KR. Pharmacology and immunology of botulinum toxin serotypes. J Neurol 2001;248(Suppl 1):3-10.
-
(2001)
J. Neurol.
, vol.248
, Issue.SUPPL. 1
, pp. 3-10
-
-
Aoki, K.R.1
-
43
-
-
0026465050
-
Psoriasiform eruption from intramuscular botulinum A toxin
-
Bowden JB, Rapini RP. Psoriasiform eruption from intramuscular botulinum A toxin. Cutis 1992;50:415-6.
-
(1992)
Cutis
, vol.50
, pp. 415-416
-
-
Bowden, J.B.1
Rapini, R.P.2
-
44
-
-
0036728393
-
Long-term prospective follow-up of botulinum toxin treatment for facial rhytids
-
Bulstrode NW, Grobelaar AO. Long-term prospective follow-up of botulinum toxin treatment for facial rhytids. Aesthetic Plast Surg 2002;26:356-9.
-
(2002)
Aesthetic Plast. Surg.
, vol.26
, pp. 356-359
-
-
Bulstrode, N.W.1
Grobelaar, A.O.2
-
45
-
-
0011111710
-
Botulinum toxin type A botox for pain and headache
-
Brin MF, Jankovic J, Hallett M, editors. Philadelphia: Lippincott Williams & Williams
-
Brin MF, Binder W, Blitzer A, et al. Botulinum toxin type A botox for pain and headache. In: Brin MF, Jankovic J, Hallett M, editors. Scientific and therapeutic aspects of botulinum toxin. Philadelphia: Lippincott Williams & Williams; 2002. p. 233-50.
-
(2002)
Scientific and Therapeutic Aspects of Botulinum Toxin
, pp. 233-250
-
-
Brin, M.F.1
Binder, W.2
Blitzer, A.3
-
46
-
-
0010584436
-
Everything you need to know about Botox injections
-
Werschler P, Baumann L. Everything you need to know about Botox injections. Skin Aging 2001;9:36-42.
-
(2001)
Skin Aging
, vol.9
, pp. 36-42
-
-
Werschler, P.1
Baumann, L.2
-
47
-
-
0001942059
-
Botulinum toxin-A risks overcome by proper technique
-
Wilson F. Botulinum toxin-A risks overcome by proper technique. Cosmetic Surgery Times 2001. p. 12-5.
-
(2001)
Cosmetic Surgery Times
, pp. 12-15
-
-
Wilson, F.1
-
48
-
-
0036147208
-
Severe, intractable headache after injection with botulinum a exotoxin: Report of 5 cases
-
Alam M. Severe, intractable headache after injection with botulinum a exotoxin: report of 5 cases. J Am Acad Dermatol 2002;46(1):62-5.
-
(2002)
J. Am. Acad. Dermatol.
, vol.46
, Issue.1
, pp. 62-65
-
-
Alam, M.1
-
49
-
-
0002929018
-
Pharmacology and histology of the therapeutic application of botulinum toxin
-
Jankovic J, Hallett M, editors. New York: Marcel Dekker
-
Borodic GE, Ferrante RJ, Pearce LB, et al. Pharmacology and histology of the therapeutic application of botulinum toxin. In: Jankovic J, Hallett M, editors. Therapy with botulinum toxin. New York: Marcel Dekker; 1994. p. 119-58.
-
(1994)
Therapy With Botulinum Toxin
, pp. 119-158
-
-
Borodic, G.E.1
Ferrante, R.J.2
Pearce, L.B.3
-
50
-
-
0030048762
-
Cosmetic denervation of the muscles of facial expression with botulinum toxin
-
Garcia A, Fulton JE. Cosmetic denervation of the muscles of facial expression with botulinum toxin. Dermatol Surg 1996;22:39-43.
-
(1996)
Dermatol. Surg.
, vol.22
, pp. 39-43
-
-
Garcia, A.1
Fulton, J.E.2
-
51
-
-
0347549714
-
Spastic frontalis: Eyelid laxity syndrome
-
Presented at the Annual Meeting of the American Society of Aesthetic Plastic Surgery. San Francisco, March 19-24
-
Ramirez OM. Spastic frontalis: eyelid laxity syndrome. Presented at the Annual Meeting of the American Society of Aesthetic Plastic Surgery. San Francisco, March 19-24, 1995.
-
(1995)
-
-
Ramirez, O.M.1
-
52
-
-
0000171902
-
Cosmetic uses of botulinum A exotoxin
-
Kelin AW, editor. New York: Marcel Dekker
-
Carruthers A, Carruthers JA. Cosmetic uses of botulinum A exotoxin. In: Kelin AW, editor. Tissue augmentation in clinical practice. New York: Marcel Dekker; 1998. p. 207-36.
-
(1998)
Tissue Augmentation in Clinical Practice
, pp. 207-236
-
-
Carruthers, A.1
Carruthers, J.A.2
-
53
-
-
0028016230
-
Botulinum toxin A for hyperkinetic facial lines: Results of a double blind, vehicle-controlled study
-
Keen M, Blitzer A, Aviv J, et al. Botulinum toxin A for hyperkinetic facial lines: results of a double blind, vehicle-controlled study. Plast Reconstruct Surgery 1994; 94:94-9.
-
(1994)
Plast. Reconstruct. Surgery
, vol.94
, pp. 94-99
-
-
Keen, M.1
Blitzer, A.2
Aviv, J.3
-
54
-
-
0030481450
-
Botulinum A exotoxin for glabellar folds: A double-blind, vehicle controlled study with an electromyographic injection techniqu
-
Lowe HJ, Maxwell A, Harper H. Botulinum A exotoxin for glabellar folds: a double-blind, vehicle controlled study with an electromyographic injection techniqu. J Am Acad Dermatol 1996;35:569-72.
-
(1996)
J. Am. Acad. Dermatol.
, vol.35
, pp. 569-572
-
-
Lowe, H.J.1
Maxwell, A.2
Harper, H.3
-
55
-
-
0018951535
-
Botulism toxin injection of extra ocular muscles as an alternative to strabismus surgery
-
Scott AB. Botulism toxin injection of extra ocular muscles as an alternative to strabismus surgery. Trans Ophthalmol Soc 1981;87:1044-9.
-
(1981)
Trans. Ophthalmol. Soc.
, vol.87
, pp. 1044-1049
-
-
Scott, A.B.1
-
56
-
-
0031724963
-
Treatment of hyper-functional lines of the face with botulinum toxin A
-
Binder WJ, Blitzer A, Brin MF. Treatment of hyper-functional lines of the face with botulinum toxin A. Dermatol Surg 1998;24(11):1198-205.
-
(1998)
Dermatol. Surg.
, vol.24
, Issue.11
, pp. 1198-1205
-
-
Binder, W.J.1
Blitzer, A.2
Brin, M.F.3
-
57
-
-
0002695115
-
Botalinum toxin and laser resurfacing for lines around the eyes
-
Blitzer WJ, Binder WJ, Boyd JB, Carruthers A, editors. Philadelphia: Lippincott Williams & Wilkins
-
Carruthers JDA, Carruthers A. Botalinum toxin and laser resurfacing for lines around the eyes. In: Blitzer WJ, Binder WJ, Boyd JB, Carruthers A, editors. Management of facial lines and wrinkles. Philadelphia: Lippincott Williams & Wilkins; 2000. p. 315-32.
-
(2000)
Management of Facial Lines and Wrinkles
, pp. 315-332
-
-
Carruthers, J.D.A.1
Carruthers, A.2
-
58
-
-
0035871699
-
A complication with aesthetic use of Botox: Herniation of the orbital fat
-
Paloma V, Samper A. A complication with aesthetic use of Botox: herniation of the orbital fat. Plast Reconstr Surg 2001;107(5):1315-6.
-
(2001)
Plast. Reconstr. Surg.
, vol.107
, Issue.5
, pp. 1315-1316
-
-
Paloma, V.1
Samper, A.2
-
59
-
-
0034949812
-
Treatment guidelines for botulinum toxin type A for the periocular region and partial upper lip ptosis following injections to the lateral canthal rhytids
-
Matarasso SL, Matarasso A. Treatment guidelines for botulinum toxin type A for the periocular region and partial upper lip ptosis following injections to the lateral canthal rhytids. Plast Reconstr Sing 2001;108(1):208-14.
-
(2001)
Plast. Reconstr. Surg.
, vol.108
, Issue.1
, pp. 208-214
-
-
Matarasso, S.L.1
Matarasso, A.2
-
60
-
-
0031782355
-
Cosmetic use of botulinum A exotoxin for the aging neck
-
Brandt FS, Bellman B. Cosmetic use of botulinum A exotoxin for the aging neck. Derm Surgery 1998;24:232-4.
-
(1998)
Derm. Surgery
, vol.24
, pp. 232-234
-
-
Brandt, F.S.1
Bellman, B.2
-
61
-
-
0026773745
-
Dysphagia following botox injections for spasmodic torticollis
-
Comella CL, Tanner CM, Defoor L, et al. Dysphagia following botox injections for spasmodic torticollis. Neurology 1992;42:1307-10.
-
(1992)
Neurology
, vol.42
, pp. 1307-1310
-
-
Comella, C.L.1
Tanner, C.M.2
Defoor, L.3
-
62
-
-
0032915609
-
Nonsurgical treatment of platysmal bands with injection of botulinum toxin A
-
Kane MAC. Nonsurgical treatment of platysmal bands with injection of botulinum toxin A. Plast Reconstr Surg 1999;103(2):656-63.
-
(1999)
Plast. Reconstr. Surg.
, vol.103
, Issue.2
, pp. 656-663
-
-
Kane, M.A.C.1
-
63
-
-
85047236587
-
Forehead brow rhytidoplasty: Reassessing the goals
-
Matarasso A, Terino EO. Forehead brow rhytidoplasty: reassessing the goals. Plast Reconstruct Surg 1994; 93(7):1378-89.
-
(1994)
Plast. Reconstruct. Surg.
, vol.93
, Issue.7
, pp. 1378-1389
-
-
Matarasso, A.1
Terino, E.O.2
|